Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Caredx Inc (CDNA)

Caredx Inc (CDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Caredx Inc 8000 Marina Boulevard Brisbane CA 94005 USA

P: 415-287-2300 F: 415-287-2450

Description:

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Key Statistics

Overview:

Market Capitalization, $K 862,278
Enterprise Value, $K 513,788
Shares Outstanding, K 53,458
Annual Sales, $ 296,400 K
Annual Net Income, $ -30,660 K
Last Quarter Sales, $ 80,630 K
Last Quarter Net Income, $ -21,700 K
60-Month Beta 1.02
% of Insider Shareholders 4.60%
Float, K 50,999
% Float 95.40%
Short Volume Ratio 0.51

Growth:

1-Year Return -75.84%
3-Year Return -26.11%
5-Year Return 335.95%
5-Year Revenue Growth 629.51%
5-Year Earnings Growth 38.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 08/04/22
Next Earnings Date 10/27/22
Earnings Per Share ttm -1.32
EPS Growth vs. Prev Qtr -10.81%
EPS Growth vs. Prev Year -925.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CDNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.09%
Return-on-Assets % -12.52%
Profit Margin % -10.34
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 2.90
Price/Cash Flow N/A
Price/Book 1.93
Book Value/Share 8.33
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar